BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Torres A, Loeches IM, Sligl W, Lee N. Severe flu management: a point of view. Intensive Care Med 2020;46:153-62. [PMID: 31912206 DOI: 10.1007/s00134-019-05868-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu Y, Wang Y, Mai H, Chen Y, Liu B, Liu Y, Ji Y, Cong X, Gao Y. Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015-2020 influenza seasons. Virol J 2022;19:11. [PMID: 35033116 DOI: 10.1186/s12985-021-01739-1] [Reference Citation Analysis]
2 O'Driscoll LS, Martin-Loeches I. Management of Severe Influenza. Semin Respir Crit Care Med 2021;42:771-87. [PMID: 34918320 DOI: 10.1055/s-0041-1735491] [Reference Citation Analysis]
3 Markussen DL, Grewal HMS, Knoop ST, Serigstad S, Kommedal Ø, Ebbesen M, Ulvestad E, Bjørneklett R; CAPNOR Study Group. Comparison of rapid molecular testing methods for detecting respiratory viruses in emergency care: a prospective study. Infect Dis (Lond) 2021;:1-8. [PMID: 34847841 DOI: 10.1080/23744235.2021.2003857] [Reference Citation Analysis]
4 Antonitsch L, Gallob R, Weidinger G, Kettenbach J. New insights and antimicrobial stewardship opportunities in viral pneumonia: five lung ultrasound cases. Wien Klin Wochenschr 2021;133:1208-14. [PMID: 34605974 DOI: 10.1007/s00508-021-01946-4] [Reference Citation Analysis]
5 Namba T, Tsuge M, Yashiro M, Saito Y, Liu K, Nishibori M, Morishima T, Tsukahara H. Anti-high mobility group box 1 monoclonal antibody suppressed hyper-permeability and cytokine production in human pulmonary endothelial cells infected with influenza A virus. Inflamm Res 2021;70:1101-11. [PMID: 34455489 DOI: 10.1007/s00011-021-01496-5] [Reference Citation Analysis]
6 Seneghini M, Albrich W. [58/m-fever, cough and severe hypoxemia : Preparation for the medical specialist examination: part 65]. Internist (Berl) 2021;62:435-9. [PMID: 34264361 DOI: 10.1007/s00108-021-01096-9] [Reference Citation Analysis]
7 Joma BH, Siwapornchai N, Vanguri VK, Shrestha A, Roggensack SE, Davidson BA, Tai AK, Hakansson AP, Meydani SN, Leong JM, Bou Ghanem EN. A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age. Infect Immun 2021;89:e0047120. [PMID: 34031128 DOI: 10.1128/IAI.00471-20] [Reference Citation Analysis]
8 Rolland-Debord C, Canellas A, Choinier P, Milon A, Debrix I, Blin E, Belaube N, Mattioni S, Millet F, Nadal M, Petit-Hoang C, Rigaud P, Rech JS, Siguier M, Sroussi D, Denis M, Amiel C, Fartoukh M, Georgin-Lavialle S, Lassel L, Parrot A, Cadranel J. Daily multidisciplinary COVID-19 meeting: Experiences from a French university hospital. Respir Med Res 2021;79:100828. [PMID: 34023794 DOI: 10.1016/j.resmer.2021.100828] [Reference Citation Analysis]
9 Póvoa P, Coelho L, Salluh J. When should we use corticosteroids in severe community-acquired pneumonia? Curr Opin Infect Dis 2021;34:169-74. [PMID: 33394726 DOI: 10.1097/QCO.0000000000000709] [Reference Citation Analysis]
10 Moreno G, Rodríguez A, Sole-Violán J, Martín-Loeches I, Díaz E, Bodí M, Reyes LF, Gómez J, Guardiola J, Trefler S, Vidaur L, Papiol E, Socias L, García-Vidal C, Correig E, Marín-Corral J, Restrepo MI, Nguyen-Van-Tam JS, Torres A. Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia. ERJ Open Res 2021;7:00888-2020. [PMID: 33718494 DOI: 10.1183/23120541.00888-2020] [Reference Citation Analysis]
11 Fragkou PC, Moschopoulos CD, Karofylakis E, Kelesidis T, Tsiodras S. Update in Viral Infections in the Intensive Care Unit. Front Med (Lausanne) 2021;8:575580. [PMID: 33708775 DOI: 10.3389/fmed.2021.575580] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Lee N, Smith SW, Hui DSC, Ye M, Zelyas N, Chan PKS, Drews SJ, Zapernick L, Wong R, Labib M, Shokoples S, Eurich DT. Development of an Ordinal Scale Treatment Endpoint for Adults Hospitalized With Influenza. Clin Infect Dis 2020:ciaa777. [PMID: 32827251 DOI: 10.1093/cid/ciaa777] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 May F, Fourati S, Mekontso Dessap A, de Prost N. Antiviral treatment strategy should be individualized in critically ill patients with severe influenza. Intensive Care Med 2020;46:1292-3. [PMID: 32291461 DOI: 10.1007/s00134-020-06032-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]